Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease

Quality of Life Research

Volumn 22, Issue 5, 2013, Pages 1065-1072

  Young, Megan K ^a   Ng, Shu Kay ^a   Mellick, George ^a   Scuffham, Paul A ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Economic evaluation; EQ 5D; Parkinson's disease; PDQ 39; Quality of life

Indexed keywords

ADULT; AGED; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DEVICES; FEMALE; HEALTH STATUS; HUMAN; LANGUAGE; MALE; MENTAL HEALTH; MIDDLE AGED; PARKINSON DISEASE; PSYCHOLOGY; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SELF CARE; SICKNESS IMPACT PROFILE; SOCIAL SUPPORT; SOCIOECONOMICS; STANDARDS; STATISTICAL MODEL; VERY ELDERLY; ARTICLE; EQUIPMENT; PSYCHOLOGICAL ASPECT; STANDARD;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; LANGUAGE; LINEAR MODELS; MALE; MENTAL HEALTH; MIDDLE AGED; PARKINSON DISEASE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF CARE; SICKNESS IMPACT PROFILE; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS;

EID: 84878707101     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-012-0231-6     Document Type: Article

References (32)

1. Winter, Y.; von Campenhausen, S.; Gasser, J.; Seppi, K.; Reese, J. P.; et al. (2010). Social and clinical determinants of quality of life in Parkinson's disease in Austria: A cohort study. Journal of Neurology, 257, 638-645.
2. Rahman, S.; Griffin, H. J.; Quinn, N. P.; Jahanshahi, M. (2008). Quality of life in Parkinson's disease: The relative importance of the symptoms. Movement Disorders, 23(10), 1428-1434.
3. Peto, V.; Jenkinson, C.; Fitzpatrick, R. (1998). PDQ-39: A review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. Journal of Neurology, 245(suppl 1), s10-s14.
4. Tickle-Degnen, L.; Ellis, T.; Saint-Hilaire, M. H.; Thomas, C. A.; Wagenaar, R. C. (2010). Self-management rehabilitation and health-related quality of life in Parkinson's disease: A randomized controlled trial. Movement Disorders, 25(2), 194-204.
5. Klepac, N.; Hajnsek, S.; Trkulja, V. (2010). Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson's disease patients. Parkinsonism and Related Disorders, 16, 21-27.
6. Scalzo, P.; Kummer, A.; Cardoso, F.; Teixeira, A. L. (2009). Depressive symptoms and perception of quality of life in Parkinson's disease. Arquivos De Neuro-Psiquiatria, 67(2-A), 203-208.
7. Schrag, A.; Geser, F.; Stampfer-Kountchev, M.; Seppi, K.; Sawires, M.; et al. (2006). Health-related quality of life in multiple system atrophy. Movement Disorders, 21(6), 809-815.
8. Schrag, A.; Selai, C.; Jahanshahi, M.; Quinn, N. P. (2000). The EQ-5D - a generic quality of life measure - is a useful instrument to measure quality of life in patients with Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 69, 67-73.
9. Kristiansen, I. S.; Bingefors, K.; Nyholm, D.; Isacson, D. (2009). Short-term cost and health consequences of duodenal levodopa infusion in advanced Parkinson's disease in Sweden: An exploratory study. Applied Health Economics and Health Policy, 7(3), 167-180.
10. Groenendaal, H.; Tarrants, M. L.; Armand, C. (2010). Treatment of advanced Parkinson's disease in the United States. Clinical Drug Intestig, 30(11), 789-798.
11. Haycox, A.; Armand, C.; Murteira, S.; Cochran, J.; Francois, C. (2009). Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting. Drugs and Aging, 26(9), 791-801.
12. Valldeoriola, F.; Morsi, O.; Tolosa, E.; Rumia, J.; Marti, M. J.; et al. (2007). Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease. Movement Disorders, 22(15), 2183-2191.
13. Winter, Y.; von Campenhausen, S.; Popov, G.; Reese, J. P.; Balzer-Geldsetzer, M.; et al. (2010). Social and clnical determinants of quality of life in Parkinson's disease in a Russian cohort study. Parkinsonism and Related Disorders, 16, 243-248.
14. Post, B.; Muslimovic, D.; van Geloven, N.; Speelman, J. D.; Schmand, B.; et al. (2011). Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease. Movement Disorders, 26(3), 449-456.
15. Visser, M.; Verbaan, D.; van Rooden, S.; Marinus, J.; van Hilten, J.; et al. (2009). A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value in Health, 12(2), 392-396.
16. Hristova, D. R.; Hristov, J. I.; Mateva, N. G.; Papathanasiou, J. V. (2009). Quality of life in patients with Parkinson's disease. Folia Medica, 51(4), 58-64.
17. Bucks, R. S.; Cruise, K. E.; Skinner, T. C.; Loftus, A. M.; Barker, R. A.; Thomas, M. G. (2011). Coping processes and health-related quality of life in Parkinson's disease. International Journal of Geriatric Psychiatry, 26, 247-255.
18. Cheung, Y. B.; Tan, L. C. S.; Lau, P. N.; Au, W. L.; Luo, N. (2008). Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index. Quality of Life Research, 17, 1173-1181.
19. Jenkinson, C.; Fitzpatrick, R.; Peto, V. (2012). The Parkinson's Disease Questionnaire: User Manual for the PDQ-39, PDQ-8 and the PDQ Summary Index. Oxford: University of Oxford Health Services Research Unit; 1998. © Copyright, Isis Innovation Limited 1993. All Rights Reserved. The authors, being Professor Crispin Jenkinson, Professor Ray Fitzpatrick and Ms Viv Peto, have asserted their moral rights.
20. Cheung, K.; Oemar, M.; Oppe, M.; Rabin, R. (2009). EQ-5D User Guide: Basic information on how to use EQ-5D Version 2.0. EuroQol Group.
21. Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35, 1095-1108.
22. Jenkinson, C.; Heffernan, C.; Doll, H.; Fitzpatrick, R. (2006). The Parkinson's Disease Questionnaire (PDQ-39): Evidence for a method of imputing missing data. Age and Ageing, 35, 497-502.
23. Ng, S. K.; Krishnan, T.; McLachlan, G. J. (2004). The EM algorithm. In J. Gentle, W. Hardle, & Y. Mori (Eds.), Handbook of computational statistics (Vol. 1, pp. 137-168). New York: Springer.
24. Little, R. J. A.; Rubin, D. B. (2002). Statistical analysis with missing data (2nd ed.). New York: Wiley.
25. Brant, R. (1990). Assessing proportionality in the proportional odds model for ordinal logistic regression. Biometrics, 46, 1171-1178.
26. Xie, F.; Pullenayegum, E. M.; Li, S. C.; Hopkins, R.; Thumboo, J.; Lo, N. N. (2010). Use of a disease-specific instrument in economic evaluations: Mapping WOMAC onto the EQ-5D utility index. Value in Health, 13, 873-878.
27. Sullivan, P. W.; Ghushchyan, V. (2006). Preference-based EQ-5D index scores for chronic conditions in the United States. Medical Decision Making, 26, 410-420.
28. Lawrence, W. F.; Jr, & Fleishman, J. A. (2004). Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample. Medical Decision Making, 24, 160-169.
29. Sullivan, P. W.; Ghushchyan, V. (2006). Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample. Medical Decision Making, 26, 401-409.
30. Luo, N.; Johnson, J. A.; Shaw, J. W.; Feeny, D.; Coons, S. J. (2005). Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and health utilities index. Medical Care, 43, 1078-1086.
31. Pullenayegum, E. M.; Tarride, J. E.; Xie, F.; Goeree, R.; Gerstein, H. C.; O'Reilly, D. (2010). Analysis of health utility data when some subjects attain the upper bound of 1: Are Tobit and CLAD models appropriate? Value in Health, 13, 487-494.
32. Hagell, P.; Whalley, D.; McKenna, S. P.; Lindvall, O. (2003). Health status measurement in Parkinson's disease: Validity of the PDQ-39 and Nottingham health profile. Movement Disorders, 18, 773-783.